Virtus Biotech Clinical Trials ETF
BBCETF · NYSE Arca
$43.62
+$0.81 (+1.89%)
EOD Nov 4, 2026
Key facts
- Expense ratio
- 0.74%
- Dividend yield (TTM)
- 1.50%
- Distributions
- Annual
- Fund net assets (Jul 2026)
- $46M
- Stocks held
- 131
- Other positions
- 1
- Turnover (last fiscal year)
- 38%
- 52-week range
- $28.73 to $56.18
Top 10 holdings
All holdings11.8% of assets in ten stocks, as of Jul 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 1.67% | 16 | |
| 1.24% | n/a | |
| 1.23% | 40 | |
| 1.21% | 10 | |
| 1.18% | 10 | |
| 1.10% | 0 | |
| 1.06% | 10 | |
| 1.06% | 10 | |
| 1.02% | n/a | |
| 0.99% | n/a |
Sector allocation
Share of the fund's assets
- Healthcare97.9%
- Technology0.7%
- Industrials0.6%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
1% of the fund's stock weight sits in companies with a Quality score above 75, 64% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States83.2%
- Cayman Islands5.3%
- Canada3.4%
- Netherlands3.0%
- Ireland1.5%
- United Kingdom1.3%
- British Virgin Islands0.8%
- Switzerland0.7%
And 1 more countries.
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyBBC pays annual. Over the last twelve months it paid $0.66 per share, a 1.50% yield at today's price. The latest payment was $0.66, ex-dividend Dec 22, 2025.
BBC questions
What does BBC invest in?+
Virtus Biotech Clinical Trials ETF is an exchange-traded fund. Its largest holdings are First Tracks Biotherapeutics, Inc. (1.67%), MBX Biosciences, Inc. (1.24%), AtaiBeckley Inc. (1.23%).
What is BBC's expense ratio?+
0.74% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $74.00 a year.
How much does BBC pay in dividends?+
BBC paid $0.66 per share over the last twelve months, a 1.50% yield at the Nov 4, 2026 close of $43.62. It pays annual.
How good are the companies BBC owns?+
Weighted by position size, the stocks in BBC average a Quality score of 20 out of 100. 1% of the fund's stock weight sits in companies scoring above 75, 64% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Jul 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to n/a. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Nov 4, 2026.